Ibrance
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Ibrance in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Ibrance.
28
Global Revenue Ranking
Recent articles on PMLiVE featuring Ibrance
Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases
Myasthenia gravis affects an estimated 700,000 people worldwide
Approximately 56,800 new cases of breast cancer are diagnosed in the UK every year
The severity of the rare autoimmune disease is heightened in paediatric patients
Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year
About 290,000 people in the US will be diagnosed with breast cancer in 2023
The surge in real-world data presents opportunities for greater understanding of patients and conditions, but it needs standardising and harmonising to liberate its full potential
The company will now offer 500 products to 45 lower-income countries on a not-for-profit basis
By Marin Martinis (left) and Michael Smith (right)
COVID-19 vaccine generated $7.8bn in the second quarter of 2021 alone
ARV-471 is currently in a phase 2 trial for the treatment of patients ER-positive, HER2-negative locally advanced or metastatic breast cancer
Data shows the ‘longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients’
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology